In a Web Summit first, day two was cancelled following government advisories on Storm Charles. The final went ahead at the Atlis Grand Hotel, where all finalists were staying, with Austria’s AURIMOD winning the 2026 KPMG Private Enterprise Global Tech Innovator competition for its pioneering approach to treating chronic pai. Its CE-marked wearable, VIVO®, activates the body’s own pain-regulating mechanisms, offering a drug-free, non-invasive alternative to medication or surgery.
11 November, 2026
18 national winners pitched to five industry-leading judges. KPMG Private Enterprise named AURIMOD the 2026 Global Tech Innovator winner before a select audience in Lisbon, Portugal, recognising its expertise in developing wearable technology for chronic pain treatment through auricular vagus nerve stimulation and its ambition to expand access to drug-free, non-invasive care.